KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Moderna (MRNA) Change in Acquisitions & Divestments: 2016-2024

Historic Change in Acquisitions & Divestments for Moderna (MRNA) over the last 9 years, with Dec 2024 value amounting to $5.6 billion.

  • Moderna's Change in Acquisitions & Divestments rose 8.81% to $1.2 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $5.5 billion, marking a year-over-year increase of 0.65%. This contributed to the annual value of $5.6 billion for FY2024, which is 0.23% down from last year.
  • According to the latest figures from FY2024, Moderna's Change in Acquisitions & Divestments is $5.6 billion, which was down 0.23% from $5.6 billion recorded in FY2023.
  • Over the past 5 years, Moderna's Change in Acquisitions & Divestments peaked at $5.6 billion during FY2023, and registered a low of $1.1 billion during FY2020.
  • Its 3-year average for Change in Acquisitions & Divestments is $4.9 billion, with a median of $5.6 billion in 2024.
  • Its Change in Acquisitions & Divestments has fluctuated over the past 5 years, first surged by 173.09% in 2021, then dropped by 0.23% in 2024.
  • Yearly analysis of 5 years shows Moderna's Change in Acquisitions & Divestments stood at $1.1 billion in 2020, then soared by 173.09% to $3.1 billion in 2021, then rose by 14.27% to $3.5 billion in 2022, then skyrocketed by 57.13% to $5.6 billion in 2023, then dropped by 0.23% to $5.6 billion in 2024.